Your browser doesn't support javascript.
loading
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
Aiello, Alessandra; Coppola, Andrea; Ruggieri, Serena; Farroni, Chiara; Altera, Anna Maria Gerarda; Salmi, Andrea; Vanini, Valentina; Cuzzi, Gilda; Petrone, Linda; Meschi, Silvia; Lapa, Daniele; Bettini, Aurora; Haggiag, Shalom; Prosperini, Luca; Galgani, Simonetta; Quartuccio, Maria Esmeralda; Bevilacqua, Nazario; Garbuglia, Anna Rosa; Agrati, Chiara; Puro, Vincenzo; Tortorella, Carla; Gasperini, Claudio; Nicastri, Emanuele; Goletti, Delia.
Afiliação
  • Aiello A; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Coppola A; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Ruggieri S; Department of Human Neurosciences, University of Rome La Sapienza, Rome, Italy.
  • Farroni C; Neuroimmunology Unit, Santa Lucia Foundation Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Altera AMG; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Salmi A; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Vanini V; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Cuzzi G; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Petrone L; Unità Operativa Semplice (UOS) Professioni Sanitarie Tecniche, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Meschi S; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Lapa D; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Bettini A; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Haggiag S; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Prosperini L; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Galgani S; Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
  • Quartuccio ME; Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
  • Bevilacqua N; Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
  • Garbuglia AR; Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
  • Agrati C; Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Puro V; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Tortorella C; Cellular Immunology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Gasperini C; Department of Pediatric Hematology and Oncology, Bambino Gesu Pediatric Hospital, Rome, Italy.
  • Nicastri E; UOC Emerging Infections and Centro di Riferimento AIDS (CRAIDS), National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy.
  • Goletti D; Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
J Neurol Neurosurg Psychiatry ; 94(4): 290-299, 2023 04.
Article em En | MEDLINE | ID: mdl-36522154

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Idioma: En Ano de publicação: 2023 Tipo de documento: Article